BR9708949A - Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homem - Google Patents
Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homemInfo
- Publication number
- BR9708949A BR9708949A BR9708949A BR9708949A BR9708949A BR 9708949 A BR9708949 A BR 9708949A BR 9708949 A BR9708949 A BR 9708949A BR 9708949 A BR9708949 A BR 9708949A BR 9708949 A BR9708949 A BR 9708949A
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- preparing
- processes
- pharmaceutical formulation
- including man
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/26—Polyhydroxylic alcohols containing only six-membered aromatic rings as cyclic part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Dental Preparations (AREA)
- Photoreceptors In Electrophotography (AREA)
- Pyrane Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9610032.6A GB9610032D0 (en) | 1996-05-14 | 1996-05-14 | Chemical compounds |
| GBGB9623775.5A GB9623775D0 (en) | 1996-11-15 | 1996-11-15 | Chemical compounds |
| PCT/EP1997/002402 WO1997043272A2 (en) | 1996-05-14 | 1997-05-13 | Benzofurans and benzopyrans as chronobiological agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708949A true BR9708949A (pt) | 1999-08-03 |
Family
ID=26309331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708949A BR9708949A (pt) | 1996-05-14 | 1997-05-13 | Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homem |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5981572A (pt) |
| EP (1) | EP0901483B1 (pt) |
| JP (1) | JP2000511518A (pt) |
| CN (1) | CN1228775A (pt) |
| AR (1) | AR007135A1 (pt) |
| AT (1) | ATE244708T1 (pt) |
| AU (1) | AU727416C (pt) |
| BR (1) | BR9708949A (pt) |
| CA (1) | CA2253802A1 (pt) |
| DE (1) | DE69723436T2 (pt) |
| DK (1) | DK0901483T3 (pt) |
| ES (1) | ES2202615T3 (pt) |
| PT (1) | PT901483E (pt) |
| TR (1) | TR199802318T2 (pt) |
| WO (1) | WO1997043272A2 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| WO1998025606A1 (en) * | 1996-12-10 | 1998-06-18 | Bristol-Myers Squibb Company | Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
| AU740554B2 (en) | 1998-06-05 | 2001-11-08 | Bristol-Myers Squibb Company | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
| US6509005B1 (en) * | 1998-10-27 | 2003-01-21 | Virginia Commonwealth University | Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler |
| US7045545B1 (en) | 1999-01-27 | 2006-05-16 | Eli Lilly And Company | Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists |
| JP2002535396A (ja) * | 1999-01-27 | 2002-10-22 | イーライ・リリー・アンド・カンパニー | セロトニン(5−ht(2c))アゴニストとしてのアミノアルキルベンゾフラン類 |
| US6680332B1 (en) | 1999-06-04 | 2004-01-20 | Euro-Celtique S.A. | Substituted 5-oxo-5,6,7,8-tetrahydro-4H-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of AMPA |
| AU5318300A (en) * | 1999-06-04 | 2000-12-28 | Sui Xiong Cai | Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa |
| US6211225B1 (en) | 1999-06-30 | 2001-04-03 | Bristol-Meyers Squibb | Heterocyclic aminopyrrolidine derivatives as melatonergic agents |
| AU5257401A (en) * | 2000-04-28 | 2001-11-12 | Asahi Chemical Ind | Novel bicyclic compounds |
| WO2002100850A1 (en) * | 2001-06-08 | 2002-12-19 | Kuraray Co., Ltd. | Processes for preparation of heterocyclic compounds |
| MXPA05002259A (es) * | 2002-08-30 | 2005-07-05 | Alcon Inc | Compuestos de 5-croman-5-il-etilamina sustituidos y uso para el tratamiento de glaucoma. |
| JP2005008631A (ja) * | 2003-05-29 | 2005-01-13 | New Industry Research Organization | ベンゾフラン化合物、およびそれを含有してなる医薬組成物 |
| US7638540B2 (en) | 2003-05-29 | 2009-12-29 | The New Industry Research Organization | Benzofuran compound and medicinal composition containing the same |
| ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
| CA2580584C (en) * | 2003-09-19 | 2015-07-28 | Galileo Pharmaceuticals, Inc. | Use of alpha-tocotrienol for treatment of mitochondrial diseases |
| EP1973868B1 (en) * | 2006-01-13 | 2015-09-09 | McGill University | Novel elatonin ligands having antidepressant activity as well as sleep inducing properties |
| WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
| CN101687810A (zh) * | 2007-04-26 | 2010-03-31 | 武田药品工业株式会社 | 双环化合物及其药物用途 |
| DE102007028925A1 (de) * | 2007-06-22 | 2008-12-24 | Saltigo Gmbh | Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden |
| FR2996845A1 (fr) * | 2012-10-12 | 2014-04-18 | Servier Lab | Nouveau procede de synthese du 3-(2-bromo-4,5-dimethoxyphenyl)propanenitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| CN103588761B (zh) * | 2013-10-22 | 2015-05-27 | 湖南大学 | N-[1-(苯并呋喃-5-基)-2-氧代乙基]苯并吡喃-4-酰胺的制备与应用 |
| EP3265070B1 (en) * | 2015-03-06 | 2019-07-03 | Repoceuticals ApS | Melatonin for preventing and treating radiation vaginitis and proctitis |
| CN106542973B (zh) * | 2015-09-16 | 2019-06-25 | 南京华威医药科技集团有限公司 | 他司美琼中间体及其制备方法 |
| KR20230066313A (ko) | 2020-06-08 | 2023-05-15 | 탁토젠 인크 | 정신 장애 또는 정신적 증강에 유리한 벤조푸란 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394382A (en) * | 1980-06-17 | 1983-07-19 | Kowa Company, Ltd. | Dihydrobenzopyran compounds and pharmaceutical composition comprising said compounds |
| AT395849B (de) * | 1991-04-04 | 1993-03-25 | Noe Christian R | Pharmakologisch aktive in position 3 substituierte alpha-aminomethyl-2benzofuranmethanole |
| US5288749A (en) * | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
-
1997
- 1997-05-13 BR BR9708949A patent/BR9708949A/pt unknown
- 1997-05-13 DE DE69723436T patent/DE69723436T2/de not_active Expired - Fee Related
- 1997-05-13 WO PCT/EP1997/002402 patent/WO1997043272A2/en not_active Ceased
- 1997-05-13 JP JP09540502A patent/JP2000511518A/ja active Pending
- 1997-05-13 PT PT97923868T patent/PT901483E/pt unknown
- 1997-05-13 TR TR1998/02318T patent/TR199802318T2/xx unknown
- 1997-05-13 CN CN97196252A patent/CN1228775A/zh active Pending
- 1997-05-13 US US09/180,441 patent/US5981572A/en not_active Expired - Fee Related
- 1997-05-13 DK DK97923868T patent/DK0901483T3/da active
- 1997-05-13 EP EP97923868A patent/EP0901483B1/en not_active Expired - Lifetime
- 1997-05-13 CA CA002253802A patent/CA2253802A1/en not_active Abandoned
- 1997-05-13 AU AU29531/97A patent/AU727416C/en not_active Ceased
- 1997-05-13 AT AT97923868T patent/ATE244708T1/de not_active IP Right Cessation
- 1997-05-13 ES ES97923868T patent/ES2202615T3/es not_active Expired - Lifetime
- 1997-05-14 AR ARP970102020A patent/AR007135A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2253802A1 (en) | 1997-11-20 |
| AU727416B2 (en) | 2000-12-14 |
| ATE244708T1 (de) | 2003-07-15 |
| AU2953197A (en) | 1997-12-05 |
| WO1997043272A2 (en) | 1997-11-20 |
| CN1228775A (zh) | 1999-09-15 |
| EP0901483A2 (en) | 1999-03-17 |
| WO1997043272A3 (en) | 1998-03-26 |
| HK1018901A1 (en) | 2000-01-07 |
| AU727416C (en) | 2001-07-19 |
| DE69723436T2 (de) | 2004-07-22 |
| AR007135A1 (es) | 1999-10-13 |
| EP0901483B1 (en) | 2003-07-09 |
| JP2000511518A (ja) | 2000-09-05 |
| US5981572A (en) | 1999-11-09 |
| DE69723436D1 (de) | 2003-08-14 |
| TR199802318T2 (xx) | 1999-03-22 |
| PT901483E (pt) | 2003-11-28 |
| ES2202615T3 (es) | 2004-04-01 |
| DK0901483T3 (da) | 2003-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9708949A (pt) | Composto formulação farmacêutica e processos de preparação dos mesmos e de tratamento de um mamífero incluindo o homem | |
| PT955995E (pt) | Utilizacao de complexos para a preparacao de composicoes de tratamento para peles sensiveis, processo de preparacao e compisicoes hipoalergenicas | |
| BR9707251A (pt) | Compostos processo para a preparação dos mesmos e composições farmacêuticas | |
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| PT1003478E (pt) | Preparacoes aquosas de aerossol contendo macromoleculas biologicamente activas e processo para a preparacao dos respectivos aerossois | |
| BR9500784A (pt) | Composto e formulação farmacêutica | |
| BR9504060A (pt) | Composto e formulação farmacêutica | |
| PT850948E (pt) | Derivados propiofenona e processo para a preparacao dos mesmos | |
| BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
| FI943141A7 (fi) | Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi | |
| FI945476L (fi) | Hitaasti vapautuvat koostumukset ja menetelmä farmaseuttisten koostumusten valmistamiseksi | |
| DE69710095D1 (de) | Pharmazeutische zubereitung zur behandlung von diabetes | |
| FI960042L (fi) | Farmaseuttisia valmisteita niukkaliukoisia aktiivisia aineita varten | |
| FI944961L (fi) | Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi | |
| FI922620A7 (fi) | Peptidijohdannainen, menetelmä sen valmistamiseksi, sitä sisältävä far maseuttinen valmiste ja menetelmä glaukooman hoitamiseksi | |
| FI964028L (fi) | Uusi farmaseuttinen formulaatio ja menetelmä | |
| BR1100329A (pt) | Composto e formulação farmacêutica | |
| FI962948A7 (fi) | Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuot tamiseksi | |
| FI962445L (fi) | Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi | |
| FI953369L (fi) | Farmaseuttiset koostumukset syöpäsairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi | |
| BR9711311A (pt) | Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem | |
| BR9408494A (pt) | Preparações para o branqueamento dos dentes | |
| EE9600139A (et) | Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks | |
| BR9707261A (pt) | Compostos processos de preparação dos mesmos e de produtos e composições farmacéuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |